Several cognitive domains show decline with increasing age, which is associated with
poorer work performance and reduced quality of life. As many nations show a rise in the …

Background Systemic inflammation is one of the underlying mechanisms of cognitive
impairment. The neutrophil-to-lymphocyte ratio (NLR) has emerged as a systemic …

A potential relationship between dysregulation of immune/inflammatory pathways and
cognitive impairment has been suggested in severe mental illnesses (SMI), such as …

Background Subjective cognitive decline (SCD) may be the first symptomatic manifestation
of Alzheimer's disease, but information on its health correlates is still sparse in Chinese …

Subjective cognitive complaints in cognitively normal individuals are a relevant predictor of
Alzheimer's disease (AD), cerebrovascular disease, and age-related tauopathy. Complaints …

Objective Our recent work reported that tumor necrosis factor-α (TNF-α) is negatively
correlated with brain-derived neurotrophic factor (BDNF) in patients with schizophrenia. A …

Multiple lines of evidence indicate that patients with chronic schizophrenia (SCZ) display
executive dysfunction across the illness course. However, the potential molecular …

Abstract Increased blood interleukin-6 (IL-6) levels are a replicated abnormality in
schizophrenia, and may be associated with smaller hippocampal volumes and greater …

Introduction Type 2 diabetes mellitus (T2DM) and major depressive disorder (MDD) are both
chronic diseases, and they are often co-morbid. Usually, T2DM and MDD are associated …

Alzheimer's disease (AD) is a chronic progressive neurodegenerative disorder. Aging is the
most significant risk factor for late-onset AD. The age-associated changes in the immune …